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Abstract
The early oncological goal of any partial nephrectomy (PN) is to achieve negative surgical margins (SMs).
Several factors have been advocated as predictors of positive SMs (PSMs) after nephron-sparing surgery
(NSS). In our study, age, upper pole tumor location, standard PN and Fuhrman 3/4 nuclear grade were found to
be independent predictors of PSMs at multivariable analysis. Further evaluations are required to verify the
oncological effect of the PSM on local and systemic recurrence.
Background: The purpose of this study was to evaluate the predictors of positive margins in one of the largest
available prospective multi-institutional studies. Patients and Methods: We evaluated all patients who underwent
NSS for radiologically diagnosed kidney tumors between January 2009 and December 2012 at 19 urological Italian
centers (Registry of Conservative Renal Surgery [RECORd] project). Preoperative and anthropometric data, comor-
bidities, intraoperative and postoperative outcomes, and histological findings were analyzed. The negative and PSMs
were compared according to the clinical and surgical variables. Multivariable logistic regression models were applied
to analyze predictors of PSMs. Results: Eight hundred consecutive patients were evaluated. Seven hundred sixty-one
(95.1%) and 39 patients (4.9%) achieved negative and PSMs, respectively. Patients with PSMs were significantly older
compared with those with negative margins (median age: 66.6 vs. 61.8 years, respectively; P ¼ .001). A higher inci-
dence of PSMs was observed when NSS was performed for renal masses located in the upper pole (P ¼ .001). A lower
rate of PSMs was found in patients treated with simple enucleation rather than standard PN (1.6% vs. 7.4%,
respectively; P < .0001). A greater incidence of PSMs was found in Fuhrman 3/4 tumors (11.3%; P < .0001). At
multivariable analysis, age (odds ratio [OR], 1.04; P ¼ .01), upper pole tumor location (OR, 2.85; P ¼ .005), standard PN
(OR, 3.45; P ¼ .004), and Fuhrman 3-4 nuclear grade (OR, 4.81; P ¼ .001) were found to be independent predictors of
PSMs. Conclusion: In our multi-institutional report, young age, simple enucleation, middle or lower tumor location,
and low-grade tumor were demonstrated to be independent predictors of negative SMs.
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166 -Introduction indicated according to signs and symptoms. Tumors were classified
Nephron-sparing surgery (NSS) has become the standard of care
for the conservative management of clinically localized renal cell
carcinoma (RCC) whenever technically feasible,1,2 offering equiva-
lent oncological results,3,4 and less renal function impairment5,6
compared with radical nephrectomy. The excision of the tumor
with a minimal margin of healthy parenchyma surrounding the
neoplasm is currently considered the standard technique for partial
nephrectomy (PN), to minimize the risk of PSMs and achieve
optimal local cancer control.1 In recent years, large series have
reported the results of simple enucleation of renal masses showing
functional and oncological results equivalent to standard PN.7 In all
cases, NSS might result in incomplete cancer removal, thus causing
PSMs, which might need additional follow-up and can lead to a
potentially increased risk of local recurrence and disease progres-
sion.8-10 In the absence of randomized trials providing strong
clinical evidence, several factors have been advocated as predictors of
PSMs after NSS, such as tumor size,11 pathological stage,9 Fuhrman
grade,12 indication for NSS (elective vs. imperative),11 and surgical
volume.13 Conversely, the surgical approach (open vs. minimally
invasive), and surgical technique (standard PN vs. SE), appear to be
unrelated to margins status, according to the largest currently
available evidence.7,14-18 We aimed to evaluate the predictors of
PSM after NSS for RCC in one of the largest available prospective
multi-institutional studies.
Patients and Methods
The Italian Registry of Conservative Renal Surgery (RECORd
project) is a 4-year prospective observational multicenter study
promoted by the Leading Urological Nonprofit Foundation
Advanced Research of the Società Italiana di Urologia. The
RECORd project includes all patients who underwent conservative
surgical treatment for radiologically diagnosed kidney tumors
between January 2009 and December 2012 at 19 urological Italian
centers, upon the approval of the study protocol by the local ethical
committee and patient acceptance of the written informed consent.
Overall, data were collected on 1055 patients. In the present study
only malignant lesions were analyzed and 255 (24.2%) cases with
benign histology were excluded. An online database was generated
which comprised 5 main folders: (1) anthropometric and preop-
erative data; (2) imaging, indications, and comorbidities; (3)
intraoperative data; (4) postoperative data; and (5) histological
analysis. All data were centrally recorded on a data server. All
preoperative anthropometric characteristics were collected: sex, age,
and body mass index (BMI). Surgical indications were defined as
elective (localized unilateral RCC with healthy contralateral
kidney), relative (localized unilateral RCC with the coexistence of
comorbidities such as diabetes, hypertension, or lithiasis that could
potentially affect kidney function in the future), and absolute
(bilateral tumors, multiple tumors, moderate to severe chronic
kidney disease, or in case of neoplasia involving an anatomically or
functionally solitary kidney). Performance status was assigned
according to the Eastern Cooperative Oncology Group (ECOG)
criteria.19 Mode of presentation was distinguished according to the
Patard classification.20 In all patients, clinical workup included at
least abdominal computed tomography (CT) scans and chest
x-rays. Chest and brain CT scans were obtained only whenClinical Genitourinary Cancer April 2015according to their location on the longitudinal plane (upper pole,
middle part, and lower pole) and on the transverse plane (anterior
surface, posterior surface, lateral margin, medial margin, perihilar)
of the kidney. According to the degree of depth into the kidney,
tumors were also subdivided into 3 growth pattern categories: (1)
prevalently ( 50%) exophytic; (2) prevalently endophytic (< 50%
exophytic); and (3) entirely endophytic. All intraoperative data
including center surgical volume, surgical approach and technique,
the decision whether or not to clamp the renal vessels, type of
ischemia, ischemia time, estimated intraoperative blood loss (EBL)
and operative time were recorded. Analyzing the full data set of
1055 cases, centers were divided in low- and high-volume, and low
and very high-volume according to the threshold of 50 and
65 interventions of NSS per year, respectively. The minimally
invasive (video laparoscopic or robot-assisted) and open approaches
and the surgical technique, performed in the form of standard PN
and SE, were adopted according to the centers’ and surgeons’
preference. Standard PN has been defined as the excision of the
tumor comprising a minimal margin of healthy peritumoral renal
parenchyma.7 SE has been defined as blunt tumor excision without
removing a visible rim of parenchymal tissue around the pseudo-
capsule.7 All surgical specimens were processed according to stan-
dard pathological procedures at each institution by experienced
uropathologists. For surgical margin (SM) evaluation the specimens
were fixed in 10% buffered formalin, and grossly analyzed. The
size, color, gross aspect (solid to cystic) were recorded and the SM
was marked with ink. After tumor dissection, samples were
performed to obtain tissue blocks at tumor, healthy parenchyma,
and surgical edges and further blocks with tumor, renal capsule,
and peritumoral fat were enclosed. The margin was considered
positive when tumor tissue was marked with ink. The margin was
considered negative when no neoplastic renal tissue was observed
on the inked edges. Tumors were pathologically staged according to
the American Joint Committee on Cancer tumor, node, metastases
classification.21 The renal epithelial neoplasm classification, out-
lined in the 2004 World Health Organization monograph, was
used to assign the histological type.22 The Fuhrman classification
was used to assign the nuclear grade.22 No central pathological slide
review was performed. All medical and surgical complications that
occurred within 30 days from surgery were recorded. The severity
of surgical complications was graded according to the modified
Clavien system.23
Statistical Analysis
Categorical variables were reported as number and percentage.
Continuous variables were reported as mean (SD) or as median and
interquartile range (IQR), as appropriate. The Student t test and the
ManneWhitney U test were used to compare continuous variables
and Pearson c2 test was used to compare categorical variables. The
negative SMs (NSMs) and PSMs were compared according to the
clinical and surgical variables. Multivariable logistic regression
models considering factors that were significantly related to SM
status at univariable analysis were applied to analyze predictors of
PSMs. Statistical significance in this study was set as P  .05. All
reported P values are 2-sided. Analyses were performed using SPSS
version 20.0 (SPSS Inc, Chicago, IL).
Table 1 Clinical Characteristics of the Entire Cohort of 800
Patients According to SM Status
Preoperative Data
Negative SM
(n [ 761;
95.2%)
Positive SM
(n [ 39;
4.8%) P
Sex, n (%)
Male 524 (94.9) 28 (5.1) .70
Female 237 (95.6) 11 (4.4)
Age
<65 Years, n (%) 406 (96.4) 15 (3.6) .07
65 Years, n (%) 355 (93.7) 24 (6.3)
Mean (SD), years 61.8 (12.6) 66.6 (8.8) .001
Median BMI (IQR) 28.7 (24.3-28.5) 26.3 (23.8-27.7) .29
Indication, n (%)
Elective/relative 707 (95.4) 34 (4.6) .18
Absolute 54 (91.5) 5 (8.5)
Symptoms at Diagnosis,
n (%)
Asymptomatic 598 (95.3) 29 (4.7) .71
Symptomatic 163 (94.4) 10 (5.6)
ECOG Performance
Status, n (%)
0 531 (95.7) 24 (4.3) .28
1 230 (93.9) 15 (6.1)
Number of Lesions, n (%)
Single 727 (95.0) 38 (5.0) .57
Multiple 34 (97.1) 1 (2.9)
Median Clinical Diameter
(IQR)
3.3 (2.3-4.0) 3.2 (2.0-3.9) .60
Clinical T Classification,
n (%)
T1a 565 (95.6) 30 (4.4) .93
T1b 176 (95.7) 8 (4.3)
T2 20 (95.2) 1 (4.8)
Tumor Side, n (%)
Right 416 (54.7) 19 (48.7) .35
Left 345 (45.3) 20 (51.3)
Tumor Growth Pattern,
n (%)
50% exophytic 577 (94.4) 34 (5.6) .22
<50% exophytic 167 (97.7) 4 (2.3)
Entirely endophytic 17 (94.4) 1 (5.6)
Tumor Site, n (%)
Polar superior 206 (90.7) 21 (9.3) .001
Mesorenal 303 (97.4) 8 (2.6)
Polar inferior 252 (96.2) 10 (3.8)
Tumor Localization, n (%)
Peri-hilar 38 (95.0) 2 (5.0) .87
Anterior face 230 (94.3) 14 (5.7)
Posterior face 217 (96.0) 9 (4.0)
Medial margin 68 (97.2) 2 (2.8)
Lateral margin 207 (94.5) 12 (5.5)
Abbreviations: BMI ¼ body mass index; ECOG ¼ Eastern Cooperative Oncology Group;
IQR ¼ interquartile range; SM ¼ surgical margin.
Riccardo Schiavina et alResults
Overall, 800 patients were evaluated. In Table 1 the clinical
characteristics of the entire cohort according to the SM status are
reported: 761 (95.1%) achieved NSMs, and 39 patients (4.9%) had
PSMs at the final pathological examination. Patients with PSMs
were significantly older compared with those with NSMs (median
age: 66.6 vs. 61.8 years, respectively; P ¼ .001). Conversely, no
statistically significant differences were found among patients with
positive and negative margins in terms of sex, BMI, indication to
NSS (elective/relative vs. imperative), symptoms at the time of
diagnosis, ECOG performance status, number of lesions, clinical
stage, and tumor side. Median (IQR) clinical diameter was 3.3
(2.3-4) cm and 3.2 (2.0-3.9) cm in patients with NSMs and PSMs,
respectively (P ¼ .6). A significantly greater incidence of PSMs was
observed when NSS was performed for renal masses located in the
upper pole compared with mesorenal or lower pole tumors
(P ¼ .001). On the contrary, the tumor growth pattern (exophytic/
endophytic) and localization (anterior, posterior, medial, lateral) did
not significantly affect the SM status.
In Table 2 the most relevant intraoperative data are summarized.
The incidence of PSMs was significantly lower after minimally
invasive NSS compared with open procedures (3.0% vs. 6.2%
respectively; P ¼ .04). According to the adopted surgical technique,
a lower rate of PSM was found in patients treated with SE rather
than standard PN (1.6% vs. 7.4%, respectively; P < .0001).
Conversely, margin status was not significantly affected by the
center’s surgical volume, considering low- versus high-volume
centers and low- versus very high-volume centers. Margin status
was not significantly affected by operative time, EBL, hilar clamp-
ing, ischemia time, and intraoperative complications. Furthermore,
no significant differences in terms of tumor histotype, pathological
diameter, and pathologic tumor evaluation (intracapsular vs.
extracapsular) were found among patients with NSMs and PSMs,
respectively (Table 3); interestingly, the incidence of PSMs was
greater in Fuhrman 3/4 tumors compared with those with lower
nuclear grade (11.3% vs. 3.1%, respectively; P < .0001; Table 3).
Results from multivariable logistic regression analysis considering
factors that were significantly related to SM status are summarized
in Table 4. Age (odds ratio [OR], 1.04; P ¼ .01), upper pole tumor
location (OR, 2.85; P ¼ .005), standard PN (OR, 3.45; P ¼ .004),
and Fuhrman 3/4 nuclear grade (OR, 4.81; P ¼ .001) were found
to be independent predictors of PSMs. Conversely, the surgical
approach (open vs. minimally invasive) was not an independent
variable (OR, 1.36; P ¼ .48) at multivariable analysis.
Discussion
When performing NSS for RCC, the complete removal of the
tumor and the avoidance of PSMs is of paramount importance, to
reach optimal long-term oncological control.1 Currently, the inci-
dence of PSMs after elective NSS ranges from 0% to 7%.10 Our
series report an overall incidence of PSMs of 4.9%, which is com-
parable to the results of other NSS series, regardless of the surgical
approach (open vs. minimally invasive).9 To our knowledge, this is
one of the largest, multi-institutional prospective studies to evaluate
the predictors of PSMs and, to our knowledge, it is the first that
included open and minimally invasive NSS in the analyses.Clinical Genitourinary Cancer April 2015 - 167
Table 2 Intraoperative Data of the Entire Cohort of 800 Pa-
tients According to SM Status
Intraoperative Data
Negative SM
(n [ 761;
95.2%)
Positive SM
(n [ 39;
4.8%) P
Center Volume, n (%)
High 559 (95.1) 29 (4.9) .90
Low 202 (95.3) 10 (4.7)
Center Volume, n (%)
Very high 322 (42.3) 20 (51.3) .27
Low 439 (57.7) 19 (48.7)
Approach, n (%)
Open 442 (93.8) 29 (6.2) .04
Minimally invasive 319 (97.0) 10 (3.0)
Technique, n (%)
Simple enucleation 306 (98.4) 5 (1.6) <.0001
Standard PN 426 (92.6) 34 (7.4)
Median Operative
Time (IQR)
130 (105-175) 147 (105-185) .49
Median EBL (IQR), mL 190 (100-300) 200 (100-300) .77
Hilar Clamping, n (%)
Not performed 278 (94.2) 17 (5.8) .37
Performed 483 (95.6) 22 (4.4)
Median Ischemia Time
(IQR), Minutes
16 (13-20) 15 (11-21) .22
Intraoperative
Complications, n (%)
Present 45 (93.7) 3 (6.3) .64
Absent 716 (95.2) 36 (4.8)
Abbreviations: EBL ¼ estimated intraoperative blood loss; IQR ¼ interquartile range; PN ¼
partial nephrectomy; SM ¼ surgical margin.
Table 3 Pathological Characteristics of the Entire Cohort of
800 Patients According to SM Status
Pathological Data
Negative SM
(n [ 761;
95.2%)
Positive SM
(n [ 39;
4.8%) P
Histotype, n (%)
Clear cell RCC 550 (95.3) 27 (4.7) .75
Papillary RCC 119 (96.7) 4 (3.3)
Chromophobe RCC 77 (96.2) 3 (3.8)
Unclassified RCC 5 (71.4) 2 (28.6) e
Other renal tumorsa 10 (76.9) 3 (23.1) e
Median Pathological
Diameter (IQR)
3.0 (2.4-4.0) 3.0 (2.2-4.0) .84
Nuclear Grade, n (%)
1-2 534 (96.9) 17 (3.1) <.0001
3-4 134 (88.7) 17 (11.3)
Pathologic Tumor
Evaluation, n (%)
Intracapsular 702 (95.5) 33 (4.5) .07
Extracapsular 56 (90.3) 6 (9.7)
Abbreviations: IQR ¼ interquartile range; RCC ¼ renal cell carcinoma; SM ¼ surgical margin.
aOther renal tumors: 8 multilocular cystic RCC, 1 sarcomatoid RCC, 2 translocation carcinoma
(microphthalmia transcription factor/transcription factor E family translocation-associated car-
cinoma), 1 mucinous tubular and spindle cell carcinoma, 1 thyroid-like follicular carcinoma of
the kidney.
Table 4 Multivariable Logistic Regression Models Accounting
for the Significant Predictors of PSM
Multivariate Analysis for PSM OR 95% CI P
Continuous Variable, Age, Year 1.04 1.00-1.08 .01
Polar Superior Lesion Tumor Site
versus Others
2.85 1.37-5.87 .005
Standard PN Technique versus SE 3.45 1.66-7.19 .004
Open Approach versus Minimally
Invasive Approach
1.36 0.58-3.19 .48
Nuclear Grade 3/4 versus 1/2 4.81 1.63-14.16 .001
Abbreviations: PN ¼ partial nephrectomy; PSM ¼ positive surgical margin; SE ¼ simple
enucleation.
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168 -In our multi-institutional study, the PSM rate was slightly greater
in patients treated with open rather than minimally invasive (either
laparoscopic or robot-assisted) NSS at univariable analysis (6.2% vs.
3.0%, respectively; P ¼ .04). Conversely, the surgical approach
failed to confirm its independent role as a predictor of PSM at
multivariable analysis (Table 4). In a recent matched-pair analysis
comparing open and robot-assisted PNs from 23 centers, Ficarra
et al found no significant difference in PSM rate among open
(5.5%) and robot-assisted (5.7%) PNs (P ¼ .98).16 Similarly,
Springer and coworkers, showing results from a retrospective single-
institutional study of 340 open and laparoscopic PNs for cT1 RCC,
found comparable incidence of PSMs between the 2 groups
(1.7% vs. 1.2%; P ¼ .09).24
It appears still controversial whether the age at the time of surgery
could be a predictor of PSMs. In our report, the rate of positive
margins was found to be slightly greater in patients older than
65 years, even if these data were not statistically significant at uni-
variable analysis (Table 1; P ¼ .07). Conversely, at the multivariable
logistic regression analysis, age as a continuous value was demon-
strated to be a significant and independent predictor of PSMs (OR,
1.04; P ¼ .01; Table 4). Such a result could be easily explained.
Basically, in older patients, renal function could be much more
impaired because of medical or cardiovascular comorbidities than inClinical Genitourinary Cancer April 2015their younger counterparts. In this scenario, urologists attempt to
spare as much healthy parenchyma as possible during NSS, to
minimize the loss of postoperative renal function, thus increasing
the risk of PSMs. This result is different than others reported in the
literature. Ani et al found that age was not independently associated
with the higher risk of PSMs at multivariable analysis (OR, 0.99;
P ¼ .3).9 Similarly, Yossepowitch and coworkers did not find any
correlation between age and SM status at univariable (OR, 1;
P ¼ .77) and multivariable (OR, 1; P ¼ .81) analysis.11
Despite the previous, historical recommendations to remove at
least 1 cm of normal-appearing renal parenchyma around the tumor
to ensure negative margins,25 the current indications for NSS have
progressively changed: indeed, according to the recognized onco-
logical safety of NSS even for T1b RCC,3,26 and to the need for
preservation of as much functioning healthy parenchyma as possible
to minimize the loss of renal function,27 NSS has moved from
maximal parenchymal resection to minimal tissue removal.20 In this
Riccardo Schiavina et alscenario, several nonrandomized studies demonstrated the onco-
logical safety of simple tumor enucleation compared with standard
PN for the treatment of cT1 RCC, with a quite lower incidence of
PSMs with respect to those observed after standard PN.7,28,29
Minervini et al, in the retrospective SATURN (Surveillance And
Treatment Update Renal Cancer) study, found a PSM rate of 0.2%
and 3.4% after SE and traditional PN, respectively (P < .001).7
Similarly, in our study the incidence of PSM was significantly less
in patients treated with SE (P < .0001; Table 1), even in multi-
variable analysis the surgical technique was confirmed as an inde-
pendent predictor of PSM (OR, 3.45; P ¼ .004; Table 4). The
reason of such a result, however, should be carefully analyzed. In
fact, the blunt enucleation of the tumor along the inflammatory
pseudocapsule, rather than a traditional resection of the surrounding
healthy parenchyma, could allow to a better respect the natural
cleavage plane, avoiding entering the mass in case of irregular shape
and leaving positive margins behind. Moreover, extensive and
established experience of surgeons performing SE in this series could
be another possible explanation of such a result. Therefore, the
present data should be regarded as a proof of noninferiority in terms
of local cancer control of SE versus standard PN but prospective
randomized series are awaited to shed light on this oncological issue.
Longitudinal location (polar vs. mesorenal), exophytic, hilar
location, and clinical dimension of the tumor (parameters that
belong to the preoperative aspects and dimensions used for an
anatomical classification of renal tumors)30 could be significant
preoperative factors able to predict the complexity of the NSS and
could be related to the risk of complications and of PSMs. It seems
reasonable that, the higher is the surgical complexity, the more
challenging it is to achieve local control and complete resection. In
our study, the rate of PSMs after NSS was significantly greater only
for upper polar tumors, rather than mesorenal or lower polar lesions
(9.3% vs. 2.6% vs. 3.8%, respectively; P ¼ .001). Moreover, the
polar location (superior vs. mesorenal/inferior) was demonstrated to
be an independent predictor of PSMs in multivariable analysis (OR,
2.85; P ¼ .005; Table 4). A worse exposure of the surgical field in
the upper pole tumors in right- and left-side tumors might render
the resection of the tumor more difficult, especially when per-
forming minimally invasive procedures. To our knowledge, no
previous series reported a correlation between tumor polar location
and the risk of PSMs. Nevertheless, in the present series, the rate of
PSMs was not influenced by the tumor growth pattern, the hilar
location, and the rim location. This agrees with the data reported in
other recently published articles. Khalifeh and coworkers, in a
multi-institutional, retrospective study of 943 consecutive robot-
assisted PNs, showed that SM status was not significantly
compromised by the hilar location, endophytic rate, or the tumor
complexity according to the nephrometric score.8
Currently, there are no convincing correlations among tumor
size, clinical stage, and incidence of PSM after NSS. Yossepowitch
et al retrospectively evaluated a cohort of 1390 patients with a mean
tumor diameter of 3.5 cm, demonstrating that increasing tumor size
was associated with a lower incidence of positive margins in uni-
variate and multivariate analyses (P ¼ .05).11 Conversely, a com-
parable incidence of PSMs between patients with tumors  4 cm
and > 4 cm has been found in other retrospective open and lapa-
roscopic series.31,32 In a recent report from the Ontario CancerRegistry that evaluated 788 open and laparoscopic PNs, Ani et al
found significant correlations between increasing tumor size and
margin status, with a 4-fold higher risk of PSM in pT1b tumors
(P ¼ .002).9 In our study the mean tumor dimension and the
clinical and pathological stage failed to correlate with PSM status.
This finding corroborates the oncological safety of NSS even in
cT1b renal tumors, regardless of the surgical approach and tech-
nique adopted.
The correlation between high nuclear grade and the incidence of
PSMs still remains controversial. Intuitively, the presence of a more
aggressive and infiltrative cancer with an irregular shape and infil-
trative growth pattern might render the tumor dissection more
challenging, thus enhancing the incidence of PSMs. Higher nuclear
grade and more unfavorable cancers have been shown to be related
to the complexity of the renal tumors, according to their anatomic
and topographic characteristics.33 In the present study, positive
margins were significantly greater in patients with Fuhrman 3/4
RCC compared with those with nuclear grade 1/2 (P < .0001).
Furthermore, higher tumor grade was found to be an independent
predictor of PSM at multivariate analysis (OR, 4.81; P ¼ .001;
Table 4). Bensalah et al retrospectively evaluated a cohort of 775
patients treated with PN and found comparable results: a greater
frequency of high-grade tumors was found in patients with PSMs
rather than in those with NSMs (30% vs. 19.4%, respectively).12
Contrasting results have been recently reported in other studies,8
in which nuclear grade was neither associated nor an independent
predictor of PSMs.
In the literature, the surgical indication (elective/relative vs.
imperative) was demonstrated to play a role in the prediction of
PSMs after PN. Yossepowitch et al, after adjusting for clinical tumor
size, found that the imperative indication was an independent
predictor of PSMs.11 Conversely, in the present study the incidence
of PSMs was not statistically influenced by the surgical indication.
Indeed, even if the rate of positive margins was greater in patients
treated with imperative NSS (8.5%) compared with those who
received an elective procedure (4.6%), this finding did not reach the
statistical significance (P ¼ .18). However, the low number of
patients treated with imperative indications in our report could have
reduced the statistical power of our analysis.
The actual clinical and oncological effect of PSMs after NSS is
controversial. Indeed, according to the currently available evidence,10
the presence of a positive margin could lead to a higher risk of local
recurrence in the ipsilateral kidney, especially in patients with high-
grade tumors. Conversely, at intermediate- and long-term follow-
up, themetastatic progression and cancer-specificmortality rates were
found to be comparable among patients with PSMs or NSMs.10
We believe that the larger number of patients treated and vari-
ables analyzed, and the prospectively maintained database are the
main strengths of our study. Moreover, its multicenter nature might
increase the external validity of the data compared with the single-
center, single-surgeon setting and provide a valid snapshot of the
incidence and predictors of PSMs in a European country in the past
4 years. As study limitations, the absence of a central pathological
review, which would have influenced the interpretation of the
specimens and the final diagnosis of SM status, and the lack of
assessment of the surgical complexity according to nephrometric
scores represent the most important limitations of the present study.Clinical Genitourinary Cancer April 2015 - 169
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170 -Conclusion
The early oncological goal of PN is to achieve negative margins.
In our multi-institutional report of open and minimally invasive
NSS, the overall rate of PSMs was 4.9%. Older age, standard PN
technique, upper polar tumor location, and high-grade tumor were
all independent predictors of PSMs. Further evaluation and follow-
up is required to verify the oncological effect of the PSM on local
and systemic recurrence.
Clinical Practice Points
 The excision of the tumor with a minimal margin of healthy
parenchyma surrounding the neoplasm is currently considered
the standard technique for PN, to minimize the risk of PSMs and
achieve optimal local cancer control.
 This study (RECORd project) includes all patients who under-
went conservative surgical treatment for radiologically diagnosed
kidney cancers between January 2009 and December 2012 at 19
Italian urological centers.
 Results from multivariable logistic regression analysis showed
that age (OR, 1.04; P ¼ .01), upper pole tumor location (OR,
2.85; P ¼ .005), standard PN (OR, 3.45; P ¼ .004), and
Fuhrman 3/4 nuclear grade (OR, 4.81; P ¼ .001) were found to
be independent predictors of PSMs.
 Conversely, the surgical approach (open vs. minimally invasive)
was not an independent variable (OR, 1.36; P ¼ .48) at
multivariable analysis.
 Further evaluation and follow-up is required to verify the
oncological effect of the PSM on local and systemic recurrence.
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